Ziprasidone hydrochloride is an atypical antipsychotic medication, marketed in the United States as Geodon.
Related categories 1
Focus on Ziprasidone
Article about this antipsychotic drug, covering pharmacology, dosage, and other topics, by Dr. Ben Green, Consultant Psychiatrist and Honorary Senior Lecturer, University of Liverpool, UK. Includes reference list.
Profile of the medication, which was approved in the U.S. in 2001 for treatment of both 'positive' and 'negative' symptoms of schizophrenia, and is also used for psychotic features of bipolar disorder.
Fact sheet provided by the National Alliance for the Mentally Ill.
Features information about dosage, usage, warnings, and side effects.
Pfizer: Geodon (Ziprasidone HCl)
Prescribing information from the manufacturer. [pdf]
Last update:June 20, 2016 at 8:23:59 UTC